Merck KGaA Wins Halt of Imports of Unauthorized IVF Drugs (1)

The U.S. International Trade Commission said Wednesday it had barred imports of unauthorized in vitro fertilization treatments by two companies based on a trademark-infringement complaint Merck KGaA’s EMD Serono filed in March 2020.

The limited exclusion order applies to FastIVF, based in Scottsdale, Ariz., and Hermes Ezcanesi of Istanbul, Turkey. They’re blocked from importing gray-market prescription in vitro fertilization drugs labeled Gonal-f, Ovidrel, or Ovitrelle, that are made by or on behalf of Merck KGaA in Darmstadt, Germany. The ITC also issued a cease-and-desist order directed to FastIVF.

The import ban is subject to a 60-day presidential review and, unless ...